Le Lézard
Classified in: Health
Subject: AWD

Ramzan M. Zakir, M.D., F.A.CC., FSCAI is recognized by Continental Who's Who


NEW BRUNSWICK, N.J., Dec. 11, 2017 /PRNewswire/ -- Ramzan M. Zakir, M.D., F.A.CC., FSCAI is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Medicine at Heart & Vascular Institute of Central New Jersey in recognition of his role as Interventional Cardiologist.      

Dedicated to offering their patients quality, comprehensive health care, Heart and Vascular Institute of Central Jersey is committed to serving their clients. In this capacity, the team at Heart and Vascular "believe in developing a strong relationship with our patients based on compassion, mutual respect and understanding."   A frontrunner in the medical industry, the healthcare facility is equipped with the latest innovations in technology and provides, "exceptional diagnostic services to help initiate a focused, personalized treatment plan to improve your health condition."  Offering a wide array of services to their clients, the facility specializes in Coronary Artery Disease, Congestive Heart Failures, Valvular Heart Disease, Cardiomyopathies, and more.  In addition, they are specialized in various diagnostic testing including, Echocardiograms and Stress tests.

Practicing since 2009, Dr. Zakir has performed thousands of successful angioplasty procedures in his role of internventional cardiologist, as well as expanding his practice to peripheral vascular diseases. He is board certified in cardiology, vascular medicine, nuclear medicine, and has recently obtained his PVI certificate for vascular ultrasound. Heart and Vascular Institute of Central Jersey is where Dr. Zakir can assess the needs of his patients prior to performing complex coronary interventions, chronic total occlusions, carotid artery stenting and endovascular interventions for patients with peripheral vascular diseases as well as venous ablations for venous insufficiency.

Throughout the course of his education and training, Dr. Zakir attended Rutgers College and completed both his internship and residency at UMDNJ ? New Jersey Medical School, and served as Chief Medical Resident through the program at Hackensack University Hospital. He is Board certified in Internal Medicine, Cardiovascular Disease, Interventional Cardiology, Echocardiography Nuclear Cardiology and Endovascular. He also speaks Urudu and Punjabi Hindi as well as English.

Clinical Assistant Professor of Medicine at Rutgers Medical School ? Robert Wood Johnson University Hospital, Dr. Zakir is involved in research and fellow training. Director of the Peripheral Vascular Program at Saint Peter's University Hospital, Dr. Zakir is the principal investigator of several clinical trials to enhance the management of patients with peripheral arterial disease. He previously served as the Director of Transradial Catherization at Robert Wood Johnson University Hospital, from 2011 to 2016.

To further his professional development, Dr. Zakir is a Fellow of the American College of Cardiology, a Fellow of the Society for Cardiac Angiography and Intervention, and a member of the Police Defense Foundation as well as Health Forces for Police. He has contributed several articles to renowned medical publications.

When not working, Dr. Zakir enjoys tennis, basketball, football, and rooting for the New York Jets, Knicks and Yankees. He dedicates this recognition to his father, Mirza, and to Saud Sadiq.

For more information, visit www.NJHeartandvascular.com.

Contact: Katherine Green, 516-825-5634, [email protected]

SOURCE Continental Who's Who


These press releases may also interest you

at 13:26
In a bid to foster excellence and innovation in the healthcare industry, the esteemed Dr. Vidal Sheen proudly announces the launch of The Dr. Vidal Sheen Grant for Healthcare Students. With a robust focus on academic prowess, compassionate care, and...

at 13:17
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...

at 13:13
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...

at 13:04
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...

at 12:30
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...



News published on and distributed by: